Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 44 Results
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib
December 13, 2021 | Abstract
Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection
October 12, 2021 | Article
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
July 22, 2021 | Abstract
Phased variants improve DLBCL minimal residual disease detection at the end of therapy
June 3, 2021 | Poster
Leveraging Phased Variants for Personalized Minimal Residual Disease Detection in Localized Non-Small Cell Lung Cancer
June 3, 2021 | Poster
Integrating genomic features for non-invasive early lung cancer detection
March 25, 2020 | Abstract
